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Abstract
Total hip replacement is a highly effective surgical procedure for patients suffering from 
end stage osteoarthritis and its success in improving symptoms of osteoarthritis has 
meant that its use has increased across many healthcare systems. Although in experi-
enced hands the procedure provides very effective outcomes one must be aware of the 
potential complications of the procedure. These can be divided into general and proce-
dure specific. General complications include infections, postoperative pulmonary issues 
and thromboembolic complications. Procedural specific complications include a surgi-
cal site infection, haemorrhage, nerve injury, dislocation, leg length discrepancy, peri-
prosthetic fractures and heterotrophic ossification. This chapter explores and describes 
the complications a surgeon may face when performing a total hip replacement and how 
one may avoid and address these.
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1. Introduction
Total hip replacement is a highly effective surgical procedure for patients suffering from end 
stage osteoarthritis [1]. Its success in improving pain, mobility and quality of life for patients 
has meant its use has increased since its introduction [2, 3].
As like any surgical procedure however, total hip replacements have associated surgical com-
plications. Thanks to advances in technology, surgical awareness and anaesthetic techniques 
the overall rates of complications have been declining despite an increasing burden of co-
morbidities in the population [4]. The complications encountered can be divided into general 
and procedure specific. This chapter will explore both aspects of complications that the sur-
geon may encounter when performing total hip replacements.
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2. General complications
2.1. Urinary tract infection
Urinary tract infections represent an approximately 13% of all healthcare-associated infec-
tion [5] and in the context of post total hip replacement is seen to be the most common minor 
postoperative compilation [6]. The estimated rates of postoperative urinary tract infections 
are at 3.26 [7]. Risk factors for the development of a urinary tract infection include female sex, 
increased age, ASA 3 or higher and the use of a general anaesthetic [6]. Of these in a recent 
multicentre study by Alvarez et al., increased age followed by female sex was the strongest 
variable in developing a postoperative urinary tract infection. As with respiratory tract infec-
tions to be discussed in the next section, urinary tract infection in the postoperative setting 
following total hip replacements have been linked to more significant adverse effects such as 
peri-prosthetic infections, implant failure and revision procedures along with the immediate 
prolonged hospital stay [8].
2.2. Postoperative pulmonary complications
Postoperative pulmonary complications are common after major surgeries and are defined 
as a collective of respiratory failure, pneumonia, pleural effusion, atelectasis, pneumothorax 
and aspiration pneumonia [9]. Postoperative pulmonary complications are a common com-
plication after total hip replacement with 45.9% patients having some form of postoperative 
pulmonary complications on postoperative CT screening [10]. The symptoms of any post-
operative pulmonary complication can vary greatly with many atelectasis following general 
anaesthesia being asymptomatic but as like urinary tract infections can cause more serious 
complications along with increased length of stay. The rate of in-patient pneumonia following 
total hip replacement is estimated to be between 0.74 and 0.86% [7].
2.3. Thromboembolic complications
2.3.1. Deep vein thrombosis
Deep vein thrombosis is a common complication following total hip replacements due to the 
venous stasis and hypercoagulability experienced both during and subsequent to the proce-
dure, adversely influencing Virchow’s triad towards a state of thrombus formation [11]. The 
subsequent results of deep vein thrombosis can vary from asymptomatic, chronic venous 
insufficiency and proximal propagation. Without the use of any prophylaxis the overall radio-
logical diagnosed rates of deep vein thrombosis has been as high as 70% in total hip replace-
ment cases [12].
With the introduction of modern thromboprophylaxis the overall rates of deep vein thrombosis 
has reduced to approximately 44% and in those that are symptomatic as low as 1.3% [13, 14]. 
Thankfully with prophylactic treatment the rate of symptomatic proximal propagation to form 
a pulmonary embolus is lower still at less than 0.6% [15].
Total Hip Replacement - An Overview124
Although half of patient who develop a deep vein thrombosis post total hip replacement have 
no identifiable risk factor there are numerous well recorded risk factors that alter Virchow’s 
triad towards a state of thrombus formation [16]. These include associated fracture, malig-
nancy, previous history of thromboembolism, immobility, obesity, pro-thrombotic conditions 
such as anti-phospholipid syndrome and the use of oral contraceptive pills. Furthermore an 
ASA grade of greater than 3 is an independent risk factor [16].
The prophylaxis for deep vein thrombosis is aimed at returning the pro-thrombotic state into 
equilibrium by adjusting the parameters of Virchow’s triad. This is done by treating the stasis 
of flow in the lower limbs both by mechanical thromboprophylaxis but also by the choice 
of anaesthetic used. A regional anaesthetic has been shown to reduce the risks of deep vein 
thrombosis over that of general anaesthetic by 50% alone due to the relative improvement in 
the flow of venous blood in the lower limbs [17]. Furthermore chemical thromboprophylaxis 
can be used to reverse the hypercoagulability. Various agents are used for chemical throm-
boprophylaxis but include low molecular weight heparin and more recently oral factor Xa 
inhibitors. Mechanical and chemical prophylaxis are utilised both intra and postoperatively 
to reduce the overall risk of deep vein thrombosis.
2.3.2. Pulmonary embolism
Deep vein thrombosis has a risk of propagating proximally through the right sided cardiac 
circulation into the pulmonary system. If the thrombus passes into the lungs they result in pul-
monary embolisms. The results of these pulmonary embolisms can vary from being asymp-
tomatic to caused catastrophic respiratory failure and can be fatal and pulmonary embolus 
being one of the leading causes of mortality post total hip replacements. The overall rates of 
postoperative total hip replacements are 3% in the absence of chemical prophylaxis [15], and 
0.21% when chemical prophylaxis is used from a recent large review [18]. The prevention of 
pulmonary embolism lies primarily in the prevention of deep vein thrombosis discussed in 
the previous section. The treatment of established pulmonary embolisms are by the use of 
therapeutic agents to inhibit the pro-thrombotic cascade and profibrinolytic agents to dissolve 
away the embolus.
2.3.3. Fat embolism
In the same way that a deep vein thrombus can pass into the pulmonary circulation, at the 
time of implant insertion the rise of intramedullary pressure from the prosthesis and cement 
can cause the embolization of medullary fat and marrow contents into the venous system 
[19, 20]. If the fat or marrow then passes into the pulmonary circulation in can pass in the 
pulmonary arteries in the same way as a venous thrombus causing much the same issues. 
These bodies of fat can also pass into the left sided circulation and cause cerebral embolisms 
and infarction causing neurological deficits [21]. By the same pattern the fat bodies can cause 
infarcts in the systemic circulation in tissues causing a classic upper body petechiae. As such 
the classic symptomatic triad of fat embolism is respiratory distress, neurological symptoms 
and upper body petechiae. To avoid such complications the intra-medullary canal is lavage 
Complications of Total Hip Replacement
http://dx.doi.org/10.5772/intechopen.76574
125
cleaned prior to implant insertion to reduce the fat content. The treatment of fat embolism is 
supportive principally for the symptoms of respiratory compromise [22].
3. Procedure-specific complications
3.1. Surgical site infection
Surgical site infections can be classified as that of superficial and deep. Whereas superficial 
infections can be a nuisance and cause prolonged hospital stays and increased morbidity for 
patients and potential for wound dehiscence the sequelae of deep infection post total hip 
replacement can be catastrophic and challenging for the clinician to manage.
At the advent of its introduction the deep infection rates for total hip replacements were 
recorded to be as high as 9.4% [23]. However in modern practice with the widespread adop-
tion of laminar flow operating theatres and prophylaxis antibiotics the current rates of deep 
infection are at between 0.3 and 1.5% [24, 25].
The prevention of deep infection is principally reducing the contamination of the surgical site 
from contaminants. These contaminants can arise from the patient’s skin, the surgical person-
nel or the surgical instruments [26]. The use of laminar flow air circulation in theatres and the 
adaptation of rigorous sterile techniques and practices in the operating room is now standard 
practice to reduce the contamination of the surgical site. However despite these best practice the 
reality is that all surgical wounds are contaminated and even the most thorough of skin prepara-
tion will not decontaminate the micro-organisms in the deeper layers of the skin and the efficacy 
of laminar air flow can be easily influence by a variety of factors in the operating room [27–29].
As the contamination of the surgical site cannot be fully eliminated the use of prophylaxis 
antibiotics is standard practice with recognised benefits to reduce the risk of deep infection 
[30, 31]. The use of prophylaxis antibiotics in total hip replacements have been shown to 
reduce the absolute risk of infection by 81% [32]. Such use of prophylaxis antibiotics is not 
without its risks however and include both the direct side effects of its use but also the increas-
ing concern of resistance. As such the choice of antibiotics is best directed by local protocols 
and guidelines and currently there is no clear consensus on the best regime [32].
Despite the effort to reduce the rates of deep infections however they do still occur and the 
diagnosis of a deep infection can be clinically challenging. The principal symptom is hip pain, 
but this along with more systemic symptoms such as fever, malaise and rigours are very vari-
able. Further the clinical examination may show signs of local inflammatory changes along 
with reduced range of motion within the hip joint.
Biochemical marks such as CRP and ESR are widely used. However in the both markers are 
non-specific and can be elevated in the presence of any concurrent inflammatory process. In 
the absence of any concurrent conditions that may increase their levels the a CRP of greater 
than 10 mg/l has a sensitivity and specificity of 96 and 92% and an ESR of over 30 mm/h that 
of 82 and 85% [33].
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Radiological investigations can aid the diagnosis with signs of osteopaenia and osteolysis 
however there is no clear way to distinguish these from aseptic loosening on plain radio-
graphs alone. Radionucelotide scanning can identify areas of increased bone turnover and 
inflammatory foci and are more sensitive and specific to deep infection. More specialist radio-
logical investigations such as labelled white cell scans and immunoglobin scans and modern 
PET scanning techniques are more sensitive and specific still, at 85.5 and 92.6% respectively 
for PET scans, but the availability remains challenging [34, 35].
Cytological and microbiological analysed sample can give both diagnostic information on 
the presence of infection but also the causative organism. Done radiologically under sterile 
conditions, a guided aspirate has been shown to have a sensitivity and specificity of 82 and 
91% [36]. A surgically performed procedure allows the concurrent washout of the surgical site 
to furthermore reduce the organism load. Any such sample however should be taken with 2 
weeks of antibiotic cleared time to avoid any false negative findings.
The treatment of deep infection in total hip replacement is based on the principles of eradi-
cation of infection and restoration of function [37]. If deep infection occurs in the acute 
period, in the first 2 weeks, then component retention may be possible with thorough 
debridement and antibiotic treatment. However such this only results in clearance of infec-
tion in 50–74% of patients [38]. More often the presence of deep infection requires a full 
revision of the total hip replacement. This can be performed as either a single or two stage 
procedure. A single stage procedure is the removal of the prosthesis with thorough clear-
ance of the infection with the implantation of a new prosthesis and subsequent antibiotics 
therapy. This differs to that of a two stage procedure whereby the first stage is the removal 
of the infected prosthesis, soft tissue debridement and the insertion of an antibiotic loaded 
spacer. After an interval of approximately 6 weeks of antibiotic therapy and the patient 
undergoes a second stage procedure with the insertion of a new prosthesis [39, 40]. The 
benefits of a single stage procedure are that of reduced operative morbidity however the 
results of successful treatment of the infection is consistently better with a two stage proce-
dure at 87–94% [41] (Figure 1).
3.2. Haemorrhage
Haemorrhage can be classified into intraoperative haemorrhage and postoperative. Arthro-
plasty surgery is associated with significant levels of haemorrhage and a relatively high 
demand of blood transfusion [42, 43]. Haemorrhage that is deemed to be clinically significant 
is difficult to determine and varies between clinician, centres and trails. One large multi-cen-
tered study defines important haemorrhage to be as “bleeding that is recorded by the surgeon as 
being outside the range of ‘typical expected levels’ of bleeding following THA/TKA, or bleeding that 
is cited as the cause of prolonged hospital stay” [44]. Rates of intraoperative haemorrhage vary 
from 2 to 3.6 unit [44–47]. Risk factors for increased intraoperative haemorrhage rates include 
increased operative time, with one study demonstrating a 1 min increase in operative time 
resulting in a 1.552 ml increase in intraoperative bleeding in total hip replacements [48]. Low 
and high BMI has been both associated with increased risk of haemorrhage [49, 50].
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Due to the high rates of intraoperative haemorrhage total hip replacement has a high rate of 
transfusion requirements. Median volume of allogenic transfusions in total hip replacements 
is 2 units [46, 47]. Autologous transfusion is also extensively used in total hip replacements 
with estimates at 20–80% of all total hip replacement patients requiring an allogenic trans-
fusion [51–57]. When autologous transfusion is used the rates of requiring only autologous 
transfusions vary from 49 to 79% [47, 58–61]. Risk factors for intraoperative blood transfusion 
are low preoperative Hb, high age, female gender, large estimated volume of intraoperative 
blood loss and American Society of Anesthesiologists score of more than 2 [49, 62].
The risks of allogenic transfusions have been widely reported to include disease transmis-
sion, haemolytic reactions, fluid and haemodynamic overload, acute lung injury, coagulopa-
thy, febrile non-haemolytic reactions as well as the a potential increased length of hospital 
stay and the financial cost [54, 63–65]. Various methods of blood management interventions 
are utilised to reduce the rates of autologous blood transfusions to include correcting any 
 preoperative anaemia, ceasing antiplatelet and anticoagulant medications, intraoperative cell 
salvage and autologous transfusions and the use tranexamic acid [66–68].
Tranexamic acid in particular has been widely adopted as an agent to reduce intraoperative 
haemorrhage. As a synthetic lysine analogue tranexamic acid acts as an antifibrolytic agent by 
inhibiting plasminogen to plasmin and therefore delays the breakdown of fibrin containing 
blood clots. Studies have shown that the administration of tranexamic acid has reduced the 
proportion of patients requiring allogenic blood transfusions but not increasing the rates of 
complications including thromboembolic events and renal failure [68, 69].
Figure 1. Management algorithm of peri-prosthetic infection.
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3.3. Nerve injury
The incidence of nerve injury following a total hip replacement is approximately between 0.05 
and 1.9% [70]. Damage to the sciatic and femoral nerve is most common, accounting for 79 
and 13% respectively, with combined nerve palsy occurring in 5.8% cases. Obturator nerve 
palsies are more rare, occurring in 1.6% of cases [71].
Risk factors for nerve injury include revision surgery, female sex and developmental dyspla-
sia of hip or acetabulum [72, 73]. The most common cause of nerve injury in total hip replace-
ment is of unknown aetiology at 47%. Other recognised causes are iatrogenic with damage 
during the operative approach, though direct laceration is rare at 1%, or due to the mechanical 
effects of limb lengthening and offset mismatch [74]. If cement is used then the direct pressure 
effect or thermal injury can cause damage to the nerve. Haematoma formation can cause dam-
age to the nerve and therefore meticulous haemostasis is important [72, 75].
There is no difference in the incidence of nerve palsy between the direct lateral or posterior 
approach [76]. When the sciatic nerve is affected it is usually the peroneal component, as it 
is more susceptible to traction and trauma [72]. Femoral nerve palsy is less common and is 
usually the result of direct compression intraoperatively by the retraction of soft tissues by 
surgical instruments.
Management of nerve injury can be challenging. The surgeon must ensure that the appropri-
ate radiological imaging, usually an ultrasound to exclude a haematoma and possibly an 
MRI, is performed to exclude a reversible cause of injury and also other causes not related to 
the surgical intervention. Nerve conduction studies may be of benefit to assess the level and 
degree of injury. If the limb has been lengthened and there are no other causes of the injury 
identified, the leg length can be addressed to reduce the stretch of the sciatic nerve. If a hae-
matoma is confirmed this may be an indication for surgery if symptoms do not resolve [72, 
77–79]. However as most causes of nerve injuries are of unknown aetiology, generally in the 
absence of a clear cause, conservative management is advocated for a postoperative neuritis 
in a multi-disciplinary approach to ensure that all other causes of nerve injuries are excluded 
[80–82]. In this manner, one would ensure close observation and follow-up to ensure gradual 
improvement in function.
3.4. Dislocation
The rate of hip dislocations can range from 0.2 to 10% with 2% of patients dislocation within 
1 year of their operation [83]. Of those who dislocate their total hip replacement, approxi-
mately one third will go on to have recurrent dislocations [84]. Risk factors are multifactorial 
and divided into patient, surgery and implant related.
3.4.1. Patient related factors
Cognitive disorders such as cerebral palsy, muscular dystrophy, dementia, advanced age 
and impaired compliance have showed increased chances of hip dislocations. Patients 
should avoid movements such as bending forward from a standing position or internal rota-
tion of a flexed hip [76, 83]. Previous hip surgery have also shown to double the risk of 
dislocations [85].
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3.4.2. Surgical risk factors
Surgical risk factors for dislocation of total hip replacements include the surgical approach, 
soft tissue tension, component design and orientation and surgeon experience. The majority 
dislocations occur posteriorly and therefore the posterior approach has the highest risk of 
dislocation. It has been documented in the literature a rate of 5.8% for the posterior approach 
in comparison to 2.3% for the anterolateral approach [85]. However recent research showing 
patients that have had a posterior capsular and external rotator repair have comparable rates 
to other approaches [76].
Implant alignment during hip replacement surgery is very important for stability of the joint. 
‘Safe zones’ for acetabular cup position are defined as an abduction angle of 40 ± 10 degrees 
and anteversion of 15 ± 10 degrees, first defined by 6 in 1978 [86]. Recent studies have shown 
that although this range can be a useful guide to acetabular position, stability of a total hip 
replacement is multifactorial and should be assessed on an individual basis and therefore the 
‘Safe Zone’ for a particular patient may lie outside this range [87].
3.4.3. Implant related factors
Component position and design can both influence the risk of dislocation. Head to neck ratio 
is very important for stability of the prosthesis and to allow a free range of movement without 
impingement. Larger femoral heads also allow a wide a mechanical range of motion when 
compare it to smaller head diameters [88]. In addition to this a larger femoral head has to 
move a greater distance away from the centre of the acetabular component before it can dis-
locate (jumping distance) therefore protecting against dislocation.
3.4.4. Management
Dislocations are initially managed by closed reduction in the majority of cases. In practice it is 
commonly seen that these patients are placed in an abduction brace though there is little evi-
dence to support their use [76]. Patients who have recurrent or irreducible dislocations with 
correctly positioned components, can be managed with restrained liners. This has become 
a relatively more recent method of treatment that can be complicated with the increase risk 
of restricted range of movement due to impingement, osteolysis due to wear debris or early 
acetabular loosening. These should be used if a cause for instability has not been identified 
and can be used as a salvage procedure [89].
Recurrent dislocations can also be treated with a bipolar hemiarthroplasty due to the larger 
head size providing additional stability. This should be reserved for elderly low demand 
patients [89].
The use of dual mobility cups in unstable hips is becoming increasingly popular. Dual mobil-
ity cups have two points of articulation allowing increased stability with less restriction on 
range of movement [90].
Poor component position, soft tissue laxity and dislocations due to impingement may require 
surgical intervention to revise their total hip replacement.
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3.5. Leg length discrepancy
Leg length discrepancy following a total hip arthroplasty is one of the most common reasons 
for patient dissatisfaction as it can cause nerve palsies, abnormal gait, lower back pain and 
reduced functional outcome. Inevitably this often leads to litigation against orthopaedic sur-
geons [91].
The incidence has been reported between 1 and 27% [92]. The measured leg length discrep-
ancy have been reported to vary from 3 to 70 mm [93]. As previous covered, nerve palsies are 
one of the most serious complications of leg length discrepancy. Sciatic and peroneal nerve 
palsies have both been associated with limb lengthening [74].
Minor leg length discrepancy of less than 1 cm may be tolerated well by the patient but more 
than 2 cm may cause gait abnormalities as well as increase in physiological demand [91, 94]. It 
is important to assess the patient preoperatively and measuring true and apparent leg lengths 
can do this. True leg length is measured from the ipsilateral anterior superior iliac spine to 
medial malleolus whereas apparent leg length is measured from the umbilicus to medial mal-
leolus. Apparent leg length discrepancies can be affected by pelvic abnormalities secondary 
to lumbar spine pathology or contractures around the hip. Leg length discrepancy that occurs 
secondary to chronic lumbar spine pathology can be very difficult to correct and may lead 
shortening or lengthening of the overall leg length.
Radiographs can be used for preoperative evaluation of leg length discrepancy and the use 
of a preoperative template to determine the level of the neck cut and position of acetabu-
lar component [95, 96]. However the reliance of preoperative templating alone has shown 
that its efficacy in avoiding any leg length discrepancy to be only 60% [96]. There are many 
 intraoperative techniques using landmarks to ensure that the correct leg length is maintained. 
One review of the literature by Desai et al. has identified over 20 methods discussed in the 
literature [91]. These methods have in common the two constant reference points, one of the 
pelvis and the other on the femur intraoperatively to ensure the leg length is maintained and 
traditionally the greater trochanter is the reference point of the femur [97].
The achievement of absolute leg length equality is challenging to achieve [98]. There must 
be adequate time allowed for any contractures to resolve and any residual minor leg length 
discrepancies can be corrected with simple shoes raises. Although a simple intervention these 
are not always well received by patients [99]. In more significant discrepancies surgical inter-
vention may be required to address the symptoms of pain and functional impairment then 
surgical correction may be required [100].
3.6. Peri-prosthetic fracture
With increasing life expectancy and an ageing population, resulting in more patients with poor 
bone quality and increase risk of falls, the number of total hip replacement is increasing. Thus 
the likelihood of patients who have had a total hip arthroplasty sustaining a peri-prosthetic 
fracture is on the rise. Furthermore with a broader indication for surgery, younger patients 
who are more active and therefore high energy trauma prone are increasingly undergoing 
such procedures, again increasing the risks of subsequent peri-prosthetic fractures [101].
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Peri-prosthetic fractures can either occur in the intraoperative or postoperative period. 
Intraoperative and postoperative peri-prosthetic have been reported at 1 and 1.1% respec-
tively. Cementless fixation are at higher risk for intraoperative peri-prosthetic fracture at 
5.4% for primary total hip replacement and 21% for revision surgery [102]. For those sustain-
ing a postoperative peri-prosthetic fracture the most significant risk factor is osteolysis with 
implant loosening [103]. The most common mechanism for peri-prosthetic fractures is a low 
energy movement accounting for over 75% of all peri-prosthetic fractures [104].
Peri-prosthetic fractures of the femur can be classified using the Vancouver classification 
(Table 1).
The management of peri-prosthetic fractures following total hip replacement is based not 
only on the fracture characteristics as defined by the Vancouver system but also patient fac-
tors including co-morbidities and bone quality. However the Vancouver classification does 
provide a well proven approach in considering the management of such injuries and we will 
briefly describe some of the approaches used in addressing such injuries.
Type A fractures are usually treated non-operatively unless a large part of the calcar is 
involved leading to instability of the prosthesis which would then require revision surgery. 
Type B fractures occur around or just distal to the stem and are most common representing 
80% of all cases [101]. B1 fractures may be treated with open reduction internal fixation with 
a combination of plate and cerclage wire system. B2 type fractures have good bone stock and 
are commonly treated with revision total hip arthroplasty with a long stem, bypassing the 
fracture site in combination with plates and cerclage wires. B3 can be the most challenging 
to treat due to the poor bone stock. These may be treated with either revision hip arthro-
plasty with structural allografts, distally fixed long stem implants or custom proximal femo-
ral replacements. Type C can be fixed using an open reduction internal fixation technique 
and there are numerous methods in use to include locking plates, screw and cable plates and 
intramedullary systems [101].
Various implants are available but treatment is very much dependent on the type of fracture, 
amount of bone stock along with taking into account patient factors. Dynamic compression 
plates (DCP) or locking compression plates (LCP) can be used in combination with cerclage 
wires and screws. Fixation of the plate can be done with either cerclage wires or unicortical 
screws. Proximal fixation with unicortical screws increases strength and therefore preferred 
Type Subtype Description
A A L Lesser trochanter
A G Greater trochanter
B B1 Well–fixed prosthesis
B2 Loose prosthesis
B3 Loose prosthesis with poor bone stock
C Fracture well below the tip of prosthesis
Table 1. The Vancouver classification for periprosthetic fractures of total hip replacements [105].
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over cerclage wires. Plates can also be biplanar to provide further stability. Various proximal 
femoral replacements are available and the choice depends on level of fracture, quality of 
bone and amount of bonestock remaining [106].
Acetabular peri-prosthetic fractures are uncommon but usually occur intraoperatively when 
inserting the acetabular component. The aim of treatment is to stabilise the fracture and pre-
vent further propagation of the implant by plating the anterior or posterior columns, using 
bone grafts and, or using jumbo revision cups if there is significant bone loss [107].
3.7. Heterotopic ossification
Heterotopic ossification is the abnormal formation of lamellar bone in extra-skeletal soft 
tissue [108]. The reported rates of heterotopic ossification post total hip replacement varies 
greatly between 0.6 and 90% [108–112]. Risk factors include male gender, previous history 
of heterotopic ossification, pre-existing hip fusion, ankylosing spondylitis, Paget’s disease, 
post traumatic osteoarthritis, osteonecrosis and rheumatoid arthritis [113]. Surgical factors 
may also play a role and include, extensive soft tissue dissection, haematoma formation, and 
excess bone debris [113].
Early changes of heterotopic ossification can be detected as early as 3 weeks on bone 
scan, 6 weeks on plain radiographs but can take up to 1 year for bone to fully mature [76]. 
Heterotopic ossification is usually asymptomatic and diagnosed on follow up radiographs. 
When symptomatic, patients most commonly present with pain and stiffness [108].
The abductor compartment is most commonly affected and is classified using the Brooker 
classification which is based on extent of heterotopic ossification seen on anteroposterior 
radiographs of the pelvis [114].
The management of heterotrophic ossification is divided into prevention and treatment once 
established. The prophylactic management was pioneered by Dhal with the administration 
of non-steroidal anti-inflammatory drugs [115]. Radiotherapy treatment in the form of 60Co 
gamma radiation or high energy X photons is also used to prevent the formation of heterotro-
phic ossification. The treatment of established heterotrophic ossification include physiother-
apy during the maturation phase to prevent further propagation and no surgical intervention 
such as radiotherapy and extracorporeal shockwave therapy [116, 117]. Interventional pro-
cedures in the form of embolization of the nutrient arteries have been used to prevent the 
formation of further heterotopic ossification [118]. Surgical excision of the lesions may be 
considered to treat the symptoms of both pain and stiffness [119, 120].
3.8. Other complications
Osteolysis and subsequent aseptic loosening are complications that can occur as a late compli-
cation in total hip arthroplasty. Osteolysis is induced by several mechanisms to include; adap-
tive bone remodelling, fluid pressure and particulate debris [121]. The principle mechanism for 
osteolysis following total hip arthroplasty is particular debris, particularly polyethylene [122]. 
These particulates are dissolved in the surrounding joint fluid that can lead to chronic inflam-
mation at the implant bone interface. This leads to a build-up of cells such as macrophages, 
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fibroblasts, giant cells, neutrophils, lymphocytes and osteoclasts. The cellular response created 
by these cells lead to resorption of bone leading to aseptic loosening and failure of the arthro-
plasty [123]. This type of complication would be treated with a revision total hip replacement.
Trochanteric bursitis can be seen in 3–17% of patients following total hip arthroplasty. This 
can be a result of irritation due to over use, change in posture, leg length discrepancy or inap-
propriate offset. This is usually treated non operatively with simple analgesia, non-steroidal 
anti-inflammatory drugs or steroid injections [124].
Finally although more of an irritation rather than a complication with significant morbidity, 
some total hip arthroplasty can have issues with squeaking. Squeaking is an issue found on 
hard on hard bearings and rates have been reported between 0.3 and 24.6% in ceramic on 
ceramic arthroplasty [125]. The sound is thought to be produced from the friction created from 
hard on hard surfaces with insufficient fluid film lubrication. Although a nuisance, there is 
currently no clear consensus on the association of squeaking with ceramic failure, but patients 
should be counselled on the issue if hard on hard bearing surfaces are to be considered [126].
4. Conclusion
Complications following total hip replacement can be broadly divided into systemic and pro-
cedure specific complications. Overall, incidence of complications have improved over time 
as surgical and anaesthetic techniques have improved along with the diagnosis and manage-
ment of such complications.
The most common systemic complication is a deep vein thrombosis. Infection is the most 
feared complication but the incidence have reduced with prophylactic antibiotics and 
improved theatre environment. Leg length is one of the most common causes of patient dis-
satisfaction and all complications can be challenging to manage for the hip surgeon. However 
despite these complications total hip replacements is one of the most successful orthopaedic 
procedures performed and continue to be widely performed across different healthcare sys-
tems with very positive patient satisfaction outcomes.
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